At the 64th ASMS Conference, Bruker introduces rapifleX™, the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX ...
ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 28, 2005--At Pittcon 2005, Bruker Daltonics Inc., an operating company of Bruker BioSciences Corporation (NASDAQ: BRKR), today announces novel smartbeam(TM) laser ...
The inimitable adaptability of MALDI-TOF/TOF systems enables tissue imaging of intact proteins, as well as of tryptic peptides brought about by on-tissue digestion. Although intact protein imaging can ...
Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...
Bruker Daltonics launches its next-generation ultrafleXtreme™ MALDI-TOF/TOF mass spectrometer, the only instrument combining true 1 kHz speed in both TOF and TOF/TOF modes with ultra-high performance ...
The Kenya Times on MSN
Kenya Becomes First in Sub-Saharan Africa to Get Life-Saving Diagnosis Technology
Kenya is now the first country in the Sub-Saharan region of Africa to receive a lifesaving diagnosis technology that cuts ...
At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for mass spectrometry-based tissue ...
The space-saving MALDI-8020 achieves performance specifications similar to those of larger, more expensive MALDI-TOF models but in a significantly smaller footprint. It improves laboratory efficiency ...
It's been 20 years since Hillenkamp and Karas developed MALDI. In that time, the soft ionization method, coupled with time-of-flight (TOF) mass spectrometry, has distinguished itself as the enabling ...
Perhaps no tool has been as instrumental to the proteomics revolution as the mass spectrometer. With the ability to deconvolute highly complex mixtures over a wide range of abundance levels, these ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results